CHANGE IN RATINGS
initiated at Jefferies with a Buy rating. Price target starts at $42 with 2008 EPS estimates at $1.72.
downgraded at Baird from Outperform to Neutral. $64 price target. Visit with management confirms near-term concerns of lower high-end clear film sales and surprise weakness in Europe.
downgraded at Merrill Lynchfrom Buy to Neutral. Estimates also cut, because of slower expected US growth.
Church & Dwight
initiated at UBS with Neutral rating. Price target starts at $48 with 2008 EPS estimates at $2.68.
Calamos Asset Management
upgraded at Credit Suisse to Outperform from Neutral based on improved fund performance and net flow expectations. Raised target price to $29 from $27.
Fifth Third Bancorp
upgraded to Market Perform at Keefe, Bruyette & Woods. $35 price target. Valuation has fallen in-line with peers, but estimates were also cut because of rising credit costs.
downgraded at Citigroup from Buy to Hold. $137 price target. Valuation call. Company has done well despite declining natural gas prices.
initiated at Jefferies with a Buy rating. Price target starts at $62 with 2008 EPS estimates at $2.75.
upgraded at Credit Suisse to Neutral from Underperform as stock essentially reached its target price -- dropping more than 20% since May. Maintained $14 target.
downgraded at Friedman, Billings Ramsey to Market Perform. $45 price target. Expect lower lung cancer sales for Erbitux, following doctor feedback to recent data.
downgraded at Merrill Lynch to Neutral. Valuation call, though the company's fundamentals and competitive positioning remain strong.
( PALM) upgraded at Morgan Keegan to Outperform. Market sentiment appears too negative ahead of new product launches. Channel checks also show surprising strength at Sprint.
upgraded at Morgan Stanley from equalweight to overweight and takes price target from $44 to $52
downgraded at Friedman, Billings Ramsey from Outperform to Market Perform. $66 price target. Valuation call, although the strong fundamental thesis remains intact.
upgraded at Bernstein to Outperform. $91 price target. 2008 estimates also raised, as margins should continue to improve at Carrier and Sikorsky.